Clinical Trials
Why Africa
- Population: ~1.5–1.6B people (~18% of world)
- Trials conducted: Only ~1% of global clinical trials
- High retention: Dropout rates US/EU = 15–40%; Africa = much lower with engaged communities
- Lower costs: Site & labor costs 30–50% less than US/EU/China
Sponsor Benefits
- Faster patient recruitment (large, diverse populations)
- Shorter timelines → faster to market
- Lower dropout = fewer delays, fewer protocol changes
- Lower overall trial cost per patient/site
- Improved diversity of trial data
Community Benefits
- Jobs created:
- Investigators & Sub-Investigators
- Research nurses & coordinators
- Data managers, lab techs, pharmacists
- Clinical project managers, regulatory experts
- Higher pay for African doctors & health workers (currently underpaid vs US/EU)
- New clinics & maternal/primary care programs left as legacy infrastructure
- Local access to new medicines & better healthcare capacity
Leadership & Partnerships
- Dr. Rao — decades of global clinical trial leadership; ensures top-tier quality & international standards
- Dr. Kofi — COO, Africa Prosperity Network + CyPrep member; connects governments, institutions, and AU partners
- APN — convenes industry, policy, and community stakeholders
- AU / Africa CDC — regulatory alignment & cross-border trial support
- CyPrep — manages all contracts, infrastructure, monitoring & staffing
The CyPrep Advantage
- Unique partnership: CyPrep + APN + AU = science + infrastructure + trust
- Cost-effective, faster, and higher-quality trials
- Creates lasting prosperity for African communities
- Manages all sponsor contracts, compliance, and oversigh
Call To Action→
Run your next trial in Africa with CyPrep.
Lower costs. Faster timelines. Global impact. Local prosperity.